Bison Wealth, LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 3 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Bison Wealth, LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,069,186
+0.6%
151,0150.0%0.21%
+5.6%
Q2 2023$1,063,146151,0150.20%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
RP Management, LLC 3,846,154$62,538,00025.44%
ORACLE INVESTMENT MANAGEMENT INC 1,720,733$27,979,0005.53%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 57,000$19,282,0004.35%
MPM BioImpact LLC 639,089$10,392,0002.79%
Parkman Healthcare Partners LLC 476,978$7,756,0002.27%
Sarissa Capital Management LP 1,390,790$22,614,0002.14%
Ghost Tree Capital, LLC 350,000$5,691,0001.24%
Lisanti Capital Growth, LLC 662,644$10,775,0001.21%
Baker Brothers Advisors 12,710,818$206,678,0001.19%
Tamarack Advisers, LP 125,000$2,033,0000.96%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders